K-ras mutation-positive (K-ras+) and -negative (K-ras-) colorectal adenomas may differ clinically and pathologically. As environmental compounds may cause mutations in the growth-related K-ras oncogene or affect clonal selection depending on mutational status, we evaluated whether the aetiology of K-ras+ and K-ras- adenomas differs. K-ras mutations in codons 12 and 13 were assessed in colorectal adenoma tissue (K-ras+: n = 81, K-ras-: n = 453). Dietary and lifestyle data were collected through questionnaires that were also administered to 709 polyp-free controls. Multiple logistic regression analyses showed that intake of vitamin B2 and monounsaturated fat were differently associated with risk of K-ras+ and K-ras- adenomas; vitamin B2 was inversely associated with K-ras- (highest vs. lowest tertile: odds ratio (OR) = 0.70, 95% confidence interval (CI) = 0.50-0.97, p trend = 0.020), but not with K-ras+ adenomas, and a positive association with monounsaturated fat was confined to K-ras- adenomas (OR = 1.57, 95% CI = 1.06-2.34, p trend = 0.029). Besides, potential, not statistically significant, differences in risk arose because red meat was distinctly positively associated with K-ras+ adenomas (OR = 1.70, 95% CI = 0.94-3.09, p trend = 0.061); total dietary and polyunsaturated fat tended to be inversely associated with risk of K-ras+ but not of K-ras- adenomas; inverse associations with dairy products, calcium, protein and tea were confined to K-ras- adenomas, and smoking was more markedly positively associated with K-ras- adenomas. No differences in risk of K-ras+ and K-ras- adenomas could be detected for other factors. In conclusion, dietary and lifestyle factors may influence risk of K-ras+ and K-ras- adenomas differently. However, epidemiological literature on diet, lifestyle and colorectal K-ras mutations is inconsistent.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.21839DOI Listing

Publication Analysis

Top Keywords

k-ras- adenomas
32
k-ras+ k-ras-
24
risk k-ras+
16
adenomas
12
k-ras-
11
k-ras+
9
diet lifestyle
8
k-ras mutation-positive
8
colorectal adenomas
8
k-ras mutations
8

Similar Publications

Aim: To investigate the correlation between doublecortin and CaM kinase-like-1 (DCAMKL-1) protein expression, K-ras gene mutation, and their impact on patient prognosis in colorectal cancer (CRC).

Methods: Immunohistochemistry was used to detect the expression of DCAMKL-1 protein in 60 cases of colorectal adenoma, 82 cases of CRC (including 65 cases of lymph node metastasis) and paraffin-embedded paracancerous intestinal mucosal tissue. K-ras gene mutations in primary CRC lesions were detected using an amplification-refractory mutation system and fluorescent polymerase chain reaction.

View Article and Find Full Text PDF

Runx3 Restoration Regresses K-Ras-Activated Mouse Lung Cancers and Inhibits Recurrence.

Cells

October 2023

Department of Biochemistry, School of Medicine, Institute for Tumor Research, Chungbuk National University, Cheongju 28644, Republic of Korea.

Oncogenic mutations occur in approximately 25% of human lung cancers and are most frequently found in codon 12 (G12C, G12V, and G12D). Mutated K-RAS inhibitors have shown beneficial results in many patients; however, the inhibitors specifically target K-RAS and acquired resistance is a common occurrence. Therefore, new treatments targeting all kinds of oncogenic mutations with a durable response are needed.

View Article and Find Full Text PDF

Role of RUNX3 in Restriction Point Regulation.

Cells

February 2023

Department of Biochemistry, College of Medicine and Institute for Tumour Research, Chungbuk National University, Cheongju 28644, Republic of Korea.

A cell cycle is a series of events that takes place in a cell as it grows and divides. At the G phase of cell cycle, cells monitor their cumulative exposure to specific signals and make the critical decision to pass through the restriction (R)-point. The R-point decision-making machinery is fundamental to normal differentiation, apoptosis, and G-S transition.

View Article and Find Full Text PDF
Article Synopsis
  • Syringocystadenoma papilliferum (SCAP), tubular adenoma (TA), and hydrocystoma (HC) are classified as benign skin tumors that may share a common morphological classification known as Tubulopapillary cystic adenoma with apocrine differentiation (TPCAa).
  • Recent studies have identified mutations in BRAF and K-Ras (KRAS) in SCAP and TA, while such mutations are not found in HC; verrucous epithelial growths have also been noted in TPCAa.
  • The presented case highlights a TPCAa with a specific BRAF mutation (V600E) and demonstrates notable BRAF VE1 immunoh
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!